ArticleCancers2024

First-Line Use of Daratumumab in Patients with Multiple Myeloma Shows Delayed Neutrophil and Platelet Engraftment after Autologous Stem Cell Transplantation: Results from a Real-Life Single-Center Study.

Massimo Martino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.